Skip to content

Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)

Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04323644
Acronym
CovidSurg
Enrollment
1000
Registered
2020-03-26
Start date
2020-01-01
Completion date
2020-09-30
Last updated
2020-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus, COVID-19, Surgery

Keywords

COVID-19, Coronavirus, Surgery

Brief summary

CovidSurg will capture real-world international data, to determine 30-day mortality in patients with COVID-19 infection who undergo surgery. This shared international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, ultimately improving their clinical care.

Detailed description

There is an urgent need to understand the outcomes of COVID-19 infected patients who undergo surgery. Capturing real-world data and sharing international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care. The primary aim of the study is to determine 30-day mortality in patients with COVID-19 infection who undergo surgery. In doing so, this will inform future risk stratification, decision making, and patient consent. CovidSurg is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk. This study does not collect any patient identifiable information (including no dates) and data will not be analysed at hospital-level.

Interventions

PROCEDURESurgery

Emergency or elective surgery

Sponsors

University of Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing ANY type of surgery in an operating theatre, this includes obstetrics AND \- The patient had COVID-19 infection either at the time of surgery or within 30 days of surgery, based on (i) positive COVID-19 lab test or computed tomography (CT) chest scan OR (ii) clinical diagnosis (no COVID-19 lab test or CT chest performed)

Exclusion criteria

* If COVID-19 infection is diagnosed \>30 days after discharge, the patient should not be included.

Design outcomes

Primary

MeasureTime frameDescription
30-day mortality30 daysDeath up to 30-days post surgery

Secondary

MeasureTime frameDescription
30-day reoperationUp to 30-days post surgeryReoperation up to 30-days post surgery
Postoperative ICU admissionUp to 30 days post surgeryAdmission to ICU post surgery
7-day mortality7 days post surgeryDeath up to 7-days post surgery
Postoperative acute respiratory distress syndrome (ARDS)Up to 30 days post surgeryAcute respiratory distress syndrome post surgery
Postoperative sepsisUp to 30 days post surgerySepsis post surgery
Postoperative respiratory failureUp to 30 days post surgeryRespiratory failure post surgery

Countries

Spain

Contacts

Primary ContactAneel Bhangu
A.A.Bhangu@bham.ac.uk+44 1216272949
Backup ContactDmitri Nepogodiev
D.Nepogodiev@bham.ac.uk+44 1216272949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026